Auna (NYSE:AUNA) has wrapped up FY 2025 with Q4 revenue of S/1.1b and a basic EPS loss of S/0.86, while trailing twelve month EPS sits at S/1.32 on revenue of S/4.4b and net income of S/97.6m. Over recent quarters the company has seen revenue move from S/1.04b in Q1 2025 to S/1.09b in Q2, S/1.12b in Q3 and S/1.13b in Q4, with quarterly EPS ranging from S/0.49 in Q1 up to S/1.11 in Q2 and S/0.65 in Q3 before swinging to a loss in Q4, alongside a trailing net profit margin of 2.2%. For investors, that mix of full year profitability, a soft Q4 print and thin margins sets up a results season where growth expectations and financial resilience are both in sharp focus.

See our full analysis for Auna.

With the headline numbers on the table, the next step is to see how this earnings profile lines up with the widely followed narratives about Auna’s growth potential, risks and long term profitability story.

Margins Stay Thin At 2.2%

• Over the last twelve months Auna generated S/4.4b in revenue and S/97.6m in net income, which works out to a 2.2% net profit margin compared with 2.5% a year earlier.
• Consensus narrative expects margins to improve over time. However, the latest Q4 swing to a S/64m loss and the small step down in trailing margin highlight that, even with five year annualized earnings growth of 15.9%, profitability is still sensitive to cost pressure and financing, especially given that interest payments are currently not well covered by earnings.

Volatile EPS Against High Growth Hopes

• Quarterly basic EPS moved from S/0.49 in Q1 2025 to S/1.11 in Q2, S/0.65 in Q3 and then to a loss of S/0.86 in Q4, while trailing twelve month EPS sits at S/1.32.
• Bulls argue Auna can grow earnings by 36.91% per year, and they point to factors like expansion in high complexity oncology and insurance. Yet the recent pattern of a profitable trailing year alongside a loss in the latest quarter suggests that any bullish margin story needs to account for swings in quarterly EPS and the fact that interest coverage remains weak.
  • Supporters of the bullish view may focus on Auna becoming profitable over the past five years with 15.9% annualized earnings growth, even though Q4 2025 itself showed a S/64m net loss.
  • They also reference revenue growth cited at 6.9% per year, which is slower than the US market. This means the optimistic case leans heavily on earnings efficiency rather than rapid top line expansion.

Some investors see this mix of rapid forecast earnings growth and bumpy reported EPS as a key tension in the bullish story for Auna, and they may want to review how those growth assumptions are built. 🐂 Auna Bull Case

Cheap On 13.5x P/E But With Debt Strain

• Auna is reported to trade on a trailing P/E of 13.5x versus 18.8x for peers and 22.3x for the US Healthcare industry, and also sits below the cited DCF fair value of S/44.03 while the current share price is S/5.20.
• Bears focus on the fact that interest payments are not well covered by earnings, and they argue that even with an apparently low P/E and a large gap to DCF fair value, the combination of a 2.2% trailing net margin and financing pressure could limit how much of that valuation gap is realized if more of the S/4.4b in revenue has to be directed to servicing debt rather than dropping to the bottom line.
  • Critics highlight that trailing net profit of S/97.6m is modest relative to revenue, which leaves less room to comfortably absorb higher interest costs.
  • The trailing margin also sits below last year’s 2.5%, so the bear narrative leans on the idea that thin profitability plus weak interest coverage can weigh on financial flexibility even when headline valuation metrics look attractive.

For readers who share the cautious view, this combination of thin margins and weak interest coverage is central to the bearish case on Auna, not just short term swings in EPS. 🐻 Auna Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Auna on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of cautious and optimistic signals feels unclear, now is a good time to look through the numbers yourself and test the narratives you find most convincing, starting with 3 key rewards and 1 important warning sign.

Explore Alternatives

Auna’s thin 2.2% net margin, weak interest coverage and Q4 loss of S/64m all point to meaningful pressure on the balance sheet and earnings resilience.

If you are uneasy about that kind of financial strain and want ideas with stronger cushions, take a look at our solid balance sheet and fundamentals stocks screener (41 results) built to spotlight companies where debt and cash flows look more robust.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.